Azetukalner (also known as XEN1101) is an investigational oral drug that activates Kv7 potassium channels, being developed for epilepsy and major depressive disorder. It offers once-daily dosing without the need for titration and is currently in advanced clinical trials. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Encukalner and XEN-1101. Its PubChem CID is 24743936.
Azetukalner
| CAS No | 1009344-33-5 |
|---|---|
| Molecular Formula | C23H29FN2O |
| Molecular Weight | 368.5 g/mol |
| Synonyms | N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Azetukalner (also known as XEN1101) is an investigational oral drug that activates Kv7 potassium channels, being developed for epilepsy and major depressive disorder.
The listed CAS number is 1009344-33-5.
The listed molecular formula is C23H29FN2O.
The listed molecular weight is 368.5 g/mol.
N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide.
The source lists Encukalner and XEN-1101.